Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|April 12, 1996
Synthesis and pharmacology of highly selective carboxy and phosphono isoxazole amino acid AMPA receptor antagonistsU Madsen, B Bang-Andersen, L Brehm, et al.
Clinical Neurology and Neurosurgery|January 1, 1984
The carpal tunnel syndrome and amyloidosis. A clinical and histological studyO W Bjerrum, C Rygaard-Olsen, B Dahlerup, et al.
Synapse (New York, N.Y.)|March 19, 2013
The dopamine D₁ receptor agonist (S)-[¹¹C]N-methyl-NNC 01-0259 is not sensitive to changes in dopamine concentration--a positron emission tomography examination in the monkey brainS J Finnema, B Bang-Andersen, M Jørgensen, et al.
International Immunopharmacology|May 22, 2001
Pyrrolidine dithiocarbamate inhibits serum-induced NF-kappaB activation and induces apoptosis in ROS 17/2.8 osteoblastsH Chae, S Chae, N Park, et al.
Journal of Fish Diseases|May 3, 2016
The epidemiology of pancreas disease in salmonid aquaculture: a summary of the current state of knowledgeM D Jansen, B Bang Jensen, M F McLoughlin, et al.
Journal of Medicinal Chemistry|August 29, 1997
Heteroaryl analogues of AMPA. Synthesis and quantitative structure-activity relationshipsB Bang-Andersen, S M Lenz, N Skjaerbaek, et al.
Chirality|October 31, 2000
Resolution, configurational assignment, and enantiopharmacology of 2-amino-3-[3-hydroxy-5-(2-methyl-2H- tetrazol-5-yl)isoxazol-4-yl]propionic acid, a potent GluR3- and GluR4-preferring AMPA receptor agonistS B Vogensen, H S Jensen, T B Stensbøl, et al.
Diseases of Aquatic Organisms|May 16, 2012
European freshwater VHSV genotype Ia isolates divide into two distinct subpopulationsS Kahns, H F Skall, R S Kaas, et al.
The Quarterly Journal of Medicine|June 1, 1992
A study of neuropathy in HIV infectionJ B Winer, B Bang, J R Clarke, et al.
The British Journal of Dermatology|October 1, 2020
Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trialJ I Silverberg, D Toth, T Bieber, et al.
Pageof 9